Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction

被引:161
|
作者
Ungar, Leo [1 ]
Altmann, Andre [1 ]
Greicius, Michael D. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Funct Imaging Neuropsychiat Disorders FIND Lab, Stanford, CA 94305 USA
关键词
Alzheimer's disease; APOE: Gender; Genetics; Aging and aging-related diseases; Neuroimaging; EPSILON; 4; ALLELE; MILD COGNITIVE IMPAIRMENT; PLACEBO-CONTROLLED TRIAL; RESTING-STATE FMRI; E TYPE-4 ALLELE; APOE GENOTYPE; GENETIC RISK; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; HIPPOCAMPAL VOLUMES;
D O I
10.1007/s11682-013-9272-x
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Alzheimer's disease (AD) is an increasingly prevalent, fatal neurodegenerative disease that has proven resistant, thus far, to all attempts to prevent it, forestall it, or slow its progression. The epsilon 4 allele of the Apolipoprotein E gene (APOE4) is a potent genetic risk factor for sporadic and late-onset familial AD. While the link between APOE4 and AD is strong, many expected effects, like increasing the risk of conversion from MCI to AD, have not been widely replicable. One critical, and commonly overlooked, feature of the APOE4 link to AD is that several lines of evidence suggest it is far more pronounced in women than in men. Here we review previous literature on the APOE4 by gender interaction with a particular focus on imaging-related studies.
引用
收藏
页码:262 / 273
页数:12
相关论文
共 50 条
  • [21] Apolipoprotein E and the neuropathology of Alzheimer's disease
    Mirra, SS
    HUMAN PATHOLOGY, 1999, 30 (10) : 1125 - 1127
  • [22] Alzheimer's disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset
    Duara, R
    Barker, WW
    LopezAlberola, R
    Loewenstein, DA
    Grau, LB
    Gilchrist, D
    Sevush, S
    StGeorgeHyslop, PH
    NEUROLOGY, 1996, 46 (06) : 1575 - 1579
  • [23] Apolipoprotein E genotyping in Alzheimer's disease
    McKeith, IG
    Morris, CM
    LANCET, 1996, 347 (9017): : 1775 - 1775
  • [24] Apolipoprotein E, memory and Alzheimer's disease
    Soininen, HS
    Riekkinen, PJ
    TRENDS IN NEUROSCIENCES, 1996, 19 (06) : 224 - 228
  • [25] Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease
    Macgowan, SH
    Wilcock, GK
    Scott, M
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1998, 13 (09) : 625 - 630
  • [26] Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender
    Craft, S
    Asthana, S
    Schellenberg, G
    Cherrier, M
    Baker, LD
    Newcomer, J
    Plymate, S
    Latendresse, S
    Petrova, A
    Raskind, M
    Peskind, E
    Lofgreen, C
    Grimwood, K
    NEUROENDOCRINOLOGY, 1999, 70 (02) : 146 - 152
  • [27] Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease
    Kim, Julia
    Fischer, Corinne E.
    Schweizer, Tom A.
    Munoz, David G.
    CURRENT ALZHEIMER RESEARCH, 2017, 14 (08) : 834 - 840
  • [28] Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease
    Seripa, Davide
    Panza, Francesco
    Franceschi, Marilisa
    D'Onofrio, Grazia
    Solfrizzi, Vincenzo
    Dallapiccola, Bruno
    Pilotto, Alberto
    AGEING RESEARCH REVIEWS, 2009, 8 (03) : 214 - 236
  • [29] Apolipoprotein E, synaptic plasticity and Alzheimer's disease
    Poirier, J
    Minnich, A
    Davignon, J
    ANNALS OF MEDICINE, 1995, 27 (06) : 663 - 670
  • [30] Apolipoprotein E genotype and gender do not predict the response to donepezil treatment in Alzheimer's disease
    Traykov, L
    Rigaud, AS
    Latour, F
    Couderc, R
    Moulin, F
    Forette, F
    NEUROLOGY, 2001, 56 (08) : A339 - A339